Skip to main contentSkip to navigation

Novartis

July 2023

  • Hospital worker in ward

    ‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare

    Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest

March 2023

  • A Novartis sign

    Novartis scraps cholesterol drug trial in blow to UK life sciences ambitions

    Swiss firm’s withdrawal from Leqvio trial with NHS dents government plans to attract post-Brexit research and investment

January 2020

  • FILE PHOTO: Logo is seen at new factory of Novartis in Stein<br>FILE PHOTO: The company's logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November 28, 2019. REUTERS/Arnd Wiegmann/File Photo

    NHS to trial twice-yearly injection alternative to statins

    Mass trial of drug inclisiran comes after health service strikes deal with Novartis

May 2019

  • Kenan Malik

    The $2m drug reveals medical research as a casino culture

    Kenan Malik
  • Novartis logo on building

    $2.1m Novartis gene therapy to become world's most expensive drug

February 2019

  • Pharma graphic

    Brexit frontline
    What are Brexit contingency plans for pharmaceutical industry?

    With fears over manufacturing costs and future investment, here’s what firms are doing

January 2019

  • Novartis logo

    Drug firm Novartis fears no-deal Brexit could put patients at risk

    Swiss company is stockpiling amid concerns about the supply and safety of medicines

November 2018

  • Young children and older patients are particularly susceptible to E coli infection.

    Big pharma 'failing to develop urgent drugs for poorest countries'

    Two-thirds of treatments identified by WHO yet to be developed, says monitor group

September 2018

  • The Novartis headquarters in Basel: it has announced it will close its Grimsby site by 2020.

    Fears hundreds of jobs could be axed as Novartis exits Grimsby

    Swiss pharmaceutical firm announces it will leave north-east site by 2020, in move not linked to Brexit

May 2018

  • FILE PHOTO: Swiss drugmaker Novartis’ logo is seen in Stein<br>FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo

    Top Novartis lawyer steps down over Michael Cohen payments

  • Nils Pratley

    Nils Pratley on finance
    BT v DT: does the German giant want less fibre?

    Nils Pratley
  • U.S. President Donald Trump’s personal lawyer Michael Cohen arrives at his hotel in New York City, U.S., May 9, 2018. REUTERS/Brendan McDermid

    Payments to Michael Cohen show how 'shadow lobbying' eludes US law

  • Novartis said it had paid Essential Consultants, a shell company set up by Cohen in Delaware. The arrangement related to ‘US healthcare policy matters’.

    Robert Mueller investigating payments to Michael Cohen, Swiss drug giant says

March 2018

  • A tub of Horlicks Night Time Drink

    Horlicks up for sale as GSK looks to fund $13bn Novartis deal

  • Pay Disparity Equal Pay Composite 3

    Gender pay gap: what we learned in week three

February 2018

  • Yannis Stournaras

    Novartis bribery claims: Greek MPs vote to investigate top politicians

  • Novartis

    Greece rocked by claims drug giant bribed former leaders

August 2017

  • This undated image made available by Novartis on Wednesday, Aug. 31, 2017 shows an IV bag of their drug Kymriah. On Wednesday, the Food and Drug Administration approved this first treatment that genetically engineers patients’ own blood cells to seek and destroy childhood leukemia. (Novartis via AP)

    US approves first cancer drug to use patient's own cells – with $475,000 price tag

    Novartis medication marketed as Kymriah treats most common type of childhood cancer, but some fear it could spur wave of highly expensive drugs

August 2016

  • A man with a pill

    Cancer drug companies cut prices to win NHS approval

  • A boy using an asthma inhaler.

    Give drugs companies credit when it’s due

About 33 results for Novartis
12
  翻译: